To see how the EpCAM expression of patient CTCs relates to that of often used cancer cell lines, we combined the measured EpCAM expression of all patient CTCs and compared this to the EpCAM expression of the five different cancer cell lines as measured over a 6 to 20-month period, as shown in Fig. 6. The gene discussed is EPCAM; the disease is cancer.